HC Wainwright Lifts Earnings Estimates for Nuvectis Pharma

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – HC Wainwright lifted their Q3 2025 earnings per share estimates for Nuvectis Pharma in a note issued to investors on Tuesday, August 12th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.26) for the quarter, up from their prior […]

Leave a Reply

Your email address will not be published.

Previous post Q3 EPS Forecast for Lisata Therapeutics Raised by Analyst
Next post Zacks Research Lowers Earnings Estimates for Kraft Heinz